streeters

Aurinia Pharmaceuticals Inc

bear

$AUPH ladies, gentlemen and everything in between or neither, this is what you call a bear trap

$AUPH smells like a bear trap like yesterday.

Not Achieved - Protect the companies intellectual property and do not put it at risk with a patent troll lawsuit for pennies.

$AUPH Neil and Robert could not have been to happy with Peter and his patent troll antics.

hold

$AUPH ZURA is up +300% and this shit cant even hold $9

I can&#39;t believe the lack of communication from this team. Hold the carrot out in front (partnership, spokeperson, stockholder value.  )

Seriously, what is his excuse this year to hold a meeting where there is no opposition voices?

They never hold gains especially this one with its history and management team

Stock price is like drunk person, cant hold any gains, always falling

Almost 2 years of wasted time no matter how long they’ll hold onto patent.

life

They could take your identity and mess your life up.

That’s how they live their lavish life at the expense of retails.

Expect a total non-sense of options gift for a gang of crooked m***f*** lazy asses that only burnt 2 years of our lives with mistaken strategies and very poor choices.

Wrong for your whole life and all your calls.

You are evil and continue to kill so many lives because you could not and will not be able to ramp up sales better than BP.

$AUPH 

This SOB CeO made everyone’s life a living hell.

To be honest I have never seen in my entire life  a company with such troubles who does not communicate and also a CEO who is not defending its SP.

It’s mind boggling how this is allowed to continue, especially with a patent life now at risk of being severely crippled.

price

- Lupkynis Price +8 % in Dec 
- Erol is Magnificent 
 
Bad: 
- Sell the fucking Company!

$AUPH Producer price index is in and not looking good.

$AUPH WTF is going on here, why all the push for good news and share price made a small move up and now it’s going to be all given back, illegal options granting, at least it should be is that why we are dropping

$AUPH poor management, proven price manipulation, sell all before the final collapse

Regardless of whatever you discuss, the price is halted.

sale

barely any advertising, terrible sales, no direction, no hunger, no work ethic.

$AUPH Unhappy with 
-&gt; 50%+ dilution in last 36 m.
-&gt; Poor performances in sales and market penetration, absurd bonuses paid to management…
-&gt; Misleading statements, promises from mgmt whom does not deliver… 

You know what to do @ 23 AGM!

This crap won&#39;t change until new leadership is in place or better ending like sale of the company.

The only thing left to do is whine and complain about sales, management, and lack of a buyout.

Greenleaf doesn’t have the experience or knowledge to make sales grow.

NOT growing sales for 3 quarters and losing money at a faster rate is not the path of a successful company.

$AUPH what the hell is wrong with this company, CEO can’t get the ball rolling, either sell the company or put in some real effort trying to advertise Lupkynis, to boost sales.

The value of the asset in PGs hands shrinks month by month as their sales numbers stink up the room.

His expertise and street credibility will boost this thing to $30 easy, especially with the Chinese.

$AUPH Yeezy, Snoop or Flavor Flav would give this dumpster fire company instant street cred !

Wall Streets brought it down to make money and now with good scripts + Settlement + Strong IP2037, they will bring it up to make money on the way up⬆️ .

Only FDA EMA approved oral drug for LN w 3 years safety history,  which shows clear improvement in eGFR compared to placebo.

I think this drug will likely be BO before FDA APPROVAL 

13% up just for today!

news

$AUPH Good news for investors  Options Flow 🤖 analysis shows upward momentum.

I guarantee if the company announced a new CEO, SP instantly rises 20% on the news alone…

$AUPH  Great news would be partnering with BMY, GSK etc… not waiting this inept CEO to tell you someone is going to help him out with marketing.

$AUPH  I believe we will see some positive news this week.

$AUPH looks like we hv triple good news.. 
1.SVB out of the way
2.

Usually good news for auph comes at a time when the market shits the bed.

With heavy intel networks, tutes or a group of individuals taking this up north, expecting some major positive news.

$AUPH I have listed 9 catalysts, which gives me confidence its share price will move higher.

Peter and BoDs got RSU recently and they want to stock price to go 🆙 ⬆️

The price in low and has lots of potential. So.

$AUPH 10 looks pretty even if it is the AH price.

are actually buys, since they are the same price as 2 minutes before

Share price is above all simple and exponential moving averages from 10d to 200d too.

$AUPH Nice price action on lower then 10 day volume average.

.very interesting spikes in the stock price

Its actually positive that &quot;they&quot; r not letting the price drop precipitously.

longs

Next few hours should be interesting for us longs as that just may happen here.

Meanwhile I will be enjoying the dance videos til it happens. GL to all longs and shorts :-)

$AUPH things are looking up for us longs here again!

Things are going to improve for hardheaded AUPH longs.

$AUPH Have a nice Thanksgiving everyone, things are going to get better for all of us longs.

$AUPH how can you not feel awful for longs here.

Hang in there longs because this one has the potential for huge ROI long term.

Ardelyx Inc

approval

$ARDX what fucking morons are selling it’s approved there are some real dumb fucks involved in this stock good let them get the fuck out. Pussys

$ARDX if we have no approval  you know they are corrupt. .

$ARDX with a 98% chance of fda approval within a few weeks, what is this crap?

Denial of approval of such product  will need a strong justification or presence of significant risk (which is not applicable for Tenapanor as elaborated in the above detailed  
analysis).

but not expecting a ton of juice upon approval 🤞

$ARDX with all due respect, this price action today is embarrassing…nasdaq up 6% we can’t even break $1.30 embarrassing for real… I won’t even be surprised if we get approval next week and we stay stagnant for a bit.

The issue raised was probably one of the only negatives for approval:  The fact that we are using &#39;surrogate&#39; endpoints rather than the correlated clinical outcome.

Tena is already approved for IBS with a solid safety profile, and phosphorus management is a real issue in the CKD community with only binders being available.

insider

One red flag in this company, despite one director buying 1m worth recently, is the low insider ownership.

$ARDX less than one dollar soon insiders doing, given how corrupt the board and CEO are .

$ARDX company doesn’t say anything, insiders don’t buy, stock trades like total crap.

Kind of thing you expect to happen to a stock if the CEO is complicit in a INSIDER Trading SCHEME. .

patient

Those laxatives your taking are not working, you need the full Fleets treatment, a complete system flush.

I still remember listening to the meeting and getting mad at Alikhani, the so called patient&#39;s advocate.

The subsequent increase in intraluminal pressure leads to decreased intestinal blood flow, and in the case of our patient, intestinal ischemia.

They got something that improve the quality of life for dialysis patients and you guys called the trash company.

$ARDX&quot; I am a board-certified nephrologist for 30 years and was very disappointed to say the least by the denial of application of Tenapanor for hyperphosphatemia in patients with CKD.

However, the enrichment strategy did not appear to reliably identify patients who would have a larger treatment response to tenapanor.

As you think about your decision, I’d like to ask you to remember me and the other patients out there like me who are looking for solutions to help them.

Company sitting on the best fundamentals ever to date and we get treated to these stupid 1 liner worthless post.

However when patients get discharged compliance will still remain an issue because nurses and doctors aren’t there watching over them and making sure they take their meds.

trading

Obvious, as hell looking at tape today this trading was far from organic.

↳ Why are you paying to be in a Trading Room?

$ARDX 
With these absurd disconnected 80-100million-share volumes, trading price purely a construction of Dark pool, HFT, MM share-swapping, etc.

In the scientific community as well as in trading feeling get fucked.

reason

what a BS TREE SHAKE by MM&#39;s today was zero reason to let this drop like they did. .

I see no reason to hold or add at this point.

There would be no other reason for the timing.

$ARDX Ok, the only reason to deny our drug is negligible efficacy.

but that the FDA had denied access to for reasons no one understood.

Must be the reason this can’t get past 1.5

There is no reason for it to fall today like this!

He is one of the reasons that the SP stays down.

If the trend of script numbers is anything to go by, guidance could be way better than Wall Street expects giving us a nice boost before FDA news.

$ARDX My best stock plays, real valuable tangible products, low float, undiscovered by the street, and severely undervalued.

This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.

$ARDX very good fda news on this conference call

And this is just a beginning, FDA approval will take it to the skies.

Pretty Bullish ER going to give us an update on FDA when and etc. .

$AKBA within 3  to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..

$ARDX when we get fda approval will be shining

This should be seen as a REALLY good thing - because they will need cashflow soon - one would expect - assumption being FDA response is close and production and marketing is about to get kicked up a notch. .

Things to look forward to..  NDA refile announcement, Q4 results, weekly IBSRELA sales increasing now that we are through the holidays, FDA approval, Japan approval, launch of Xphozah.

They just got approval for 1 drug from FDA and things are bot going well there..

$ARDX Looking good, would be nice to finish the day in the 4&#39;s 
 
Still waiting on positive news from the company.

$ARDX just keeps doing things well, and good news should arrive soon!

$ARDX LOL, soon Xenopah News  😁 
Stay in, or buy

$ARDX good news coming man let’s goooooo

application

$ARDX I am thrilled that the chairwoman of our Adcom gave monotherapy a thumbs up.

Better than money in the bank with soon resubmission and approval 2-6 months later!

So glad that I bought before ADCOM meeting.

$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.

bull

🎉

Have a great evening bulls and longs. 🍻🍻🍻

Hold strong bulls we’re not going anywhere 😤

$ARDX I’ll see you bulls in the 3.90s today 😤

$ARDX wow and just like that there’s no more bulls 🤣🤣🤣

A close above 4 will be huge for the bulls

Cheers and see you all tomorrow bulls and longs. 🍻

$ARDX  Looks like a bull flag on the daily morning here.

$ARDX $APRN $BLBX Have a great night, Bulls and Bull-ettes! !

Lexicon Pharmaceuticals Inc

$LXRX 
I love CNBC’s banners at open “DOW down 500 on disappointing inflation numbers“
Two hours later “Bow up 500 on hot inflation numbers”
It’s official Wall Street has turned into Las Vegas gone are the days of long term investments

$LXRX 
“ buy when there is blood in the streets”

Bought more today, I keep searching for a reason to sell and all I find are new reasons to buy!

$LXRX fda meeting went very well on to labeling  ..  seems great  ..

After this late stage fda meeting.. Then the meeting was a success  ..  and this going up. .

PLX already received a positive opinion for EMA approval  .. that&#39;s best now. .

.this should be $15 
I would say the chances of approval are pretty high!

Lonnel did a great job finally sounding confident of Sotagilflozin’s approval.

line

He had one line I loved “the promise of LX9211 in a field littered with failures” sounds like they have a partner picked out and are working on the details.

Bottom line: Good and consistent results from both P2 trials - supporting moving to P3 trial.

$LXRX 
$PHVS goes up 340% on phase 1/2 top line read out

partner

$LXRX 

Great results/talk
Great Q&amp;A
They are looking for partners!!

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Mar, 8, 2023

Mar, 1, 2023

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Feb, 8, 2023

Oct, 20, 2022

Divihomes is Now Live

LXRX

Lexicon Pharmaceuticals Inc

-7.29%

$2.47 - $2.29

Oct, 13, 2022

Sep, 29, 2022

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Mar, 8, 2023

Mar, 1, 2023

Feb, 28, 2023

Nov, 16, 2022

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Feb, 8, 2023

Oct, 20, 2022

LXRX

Lexicon Pharmaceuticals Inc

-7.29%

$2.47 - $2.29

Oct, 13, 2022

Sep, 29, 2022